Evidence map›Paper›PMID 42539775›Full record

ArticleCrohn's & colitis 3602026

Nutrition management and self-perceived relapse triggers in patients with inflammatory bowel disease: results from the 3R web-based survey.

Motohiro Esaki, Takayuki Matsumoto, Fumihito Hirai, Takahiro Suzuki, Yoshiyuki Hosoi, Akira Oota, Masaaki Higashikawa, Minami Umeyama, Masato Ueno

Abstract read
In one paragraph

Article in Crohn's & colitis 360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Motohiro EsakiDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.ORCID https://orcid.org/0000-0002-1195-0074
Takayuki MatsumotoDivision of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan.ORCID https://orcid.org/0000-0001-9786-3854
Fumihito HiraiDepartment of Gastroenterology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-5493-5675
Takahiro SuzukiMedical Department, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0004-2054-394X
Yoshiyuki HosoiMedical Department, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0009-7275-8009
Akira OotaPharmaceutical Development Department, Data Science Group, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0001-6319-1305
Masaaki HigashikawaPharmaceutical Development Department, Data Science Group, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0003-3357-7412
Minami UmeyamaMedical Department, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0007-0601-1674
Masato UenoMedical Department, EA Pharma, Tokyo, Japan.ORCID https://orcid.org/0009-0007-2410-1032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), requires long-term management. Besides pharmacotherapy, nutritional care is considered to be important; however, its real-world status in Japan remains unclear. Methods: In this study, a web-based survey on 150 patients with IBD (CD, 75; UC, 75) was conducted between October 30 and November 4, 2025. Patient demographics, self-perceived relapse frequency, self-perceived relapse triggers, implementation of nutritional therapy, and the use of health management apps were evaluated. Results: Patients with CD reported a higher self-perceived relapse frequency than did patients with UC (≥1 episode/year: 52% vs 32%) and were more likely to perceive diet as a self-perceived relapse trigger (77% vs 39%). Nutritional therapy was introduced in 53% of patients with CD and 12% of patients with UC, and 31% of patients with CD were currently using elemental diets. Most patients consumed 300-900 kcal/day, and some reported symptom improvement, although discontinuation was often due to the physician's decision or difficulty in intake. Dietary management awareness was higher in the CD group than in the UC group (77% vs 48%), whereas supplement use showed no significant difference (37% vs 29%). Health app usage was <10%, with common reasons for nonuse being a lack of awareness and perceived necessity. Conclusions: Nutritional therapy is more frequently administered to patients with CD in Japan, suggesting its clinical relevance. Strategies are required to enhance dietary guidance, support the continued use of elemental diets, and promote digital health tools.

Indexed as

adherenceCrohn’s diseaseenteral nutritionself-perceived relapseulcerative colitis

Identifiers

PMID42539775
PMCPMC13424441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.